Glioma
Conditions
Brief summary
Standard uptake values (SUVs) of 68Ga-NOTA-AE105 evaluated on uPAR-PET/MRI scan performed within 1 hour following injection of 68Ga-NOTA-AE105, compared with immunohistochemistry of uPAR (semiquantitative)
Detailed description
The prognostic significance of uPAR expression, as assessed by uPAR-PET/MRI, will be evaluated for its correlation with overall and progression free survival. Patients will be followed for a total of 36 months post uPAR-PET/MRI
Interventions
DRUG[68Ga]NOTA-AE105
Sponsors
Rigshospitalet
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake values (SUVs) of 68Ga-NOTA-AE105 evaluated on uPAR-PET/MRI scan performed within 1 hour following injection of 68Ga-NOTA-AE105, compared with immunohistochemistry of uPAR (semiquantitative) | — |
Secondary
| Measure | Time frame |
|---|---|
| The prognostic significance of uPAR expression, as assessed by uPAR-PET/MRI, will be evaluated for its correlation with overall and progression free survival. Patients will be followed for a total of 36 months post uPAR-PET/MRI | — |
Countries
Denmark
Outcome results
None listed